Pulmicort inhaler discontinued

Asthma patients using Pulmicort CFC-free inhaler need to transfer to a suitable alternative
Asthma patients using Pulmicort CFC-free inhaler need to transfer to a suitable alternative

AstraZeneca has discontinued production of the Pulmicort (budesonide) CFC-free pressurised metered-dose inhaler and the NebuChamber spacer owing to manufacturing difficulties relating to technical aspects of the inhaler.

Patients can continue using Pulmicort inhaler until their supply is finished. They will then need to be transferred to an appropriate alternative such as Pulmicort Turbohaler, Easyhaler Budesonide or Budelin Novolizer.

Healthcare professionals should note that these products may require different inhalation techniques to Pulmicort. Patients may need to be advised and assessed on correct usage. Some preparations contain lactose and therefore should not be used in patients who are lactose intolerant.

Further information: AstraZeneca

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases